Team 1: Endothelial dysfunction & Therapeutic innovation
Christophe Guignabert and Marc Humbert
Group 2: Therapeutic innovations & Bio-artificial lung
Pr Olaf Mercier, Pr Elie Fadel
Pr Olivier Sitbon, Pr Marc Humbert
|
Registries, management and innovative therapies
Objective 1:
Development and monitoring of a shared National web-based Registry on pulmonary arterial hypertension and chronic thrombo-embolic pulmonary hypertension
Objective 2:
Development of innovative therapeutic strategies: combination therapies and novel agents